Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

‘Battle for Health Justice’: Dr. Alakija Addresses Global Rheumatology Inequities

Ruth Jessen Hickman, MD  |  Issue: December 2021  |  November 10, 2021

Echoing key areas of concern more broadly in rheumatology, the task force aims to increase awareness of unmet needs, prevent morbidity from these illnesses and promote better access to treatment. The task force has collaborated with many charities and patient organizations around the world on many different initiatives related to disease awareness, advocacy, policy and education, as well as different webinar programs and virtual meetings that provide an opportunity to engage healthcare workers who are not specialists.

Like several others at the conference, Dr. Foster pointed out that such an approach is a way to reach a large number of people at low cost, and that innovations and cultural changes in technology use due to COVID-19 may be harnessed to positive effect.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Many of these free online activities rely on another resource that some task force members helped develop: Paediatric Musculoskeletal Matters (PMM), a free e-resource and online learning tool on pediatric musculoskeletal curricula designed to serve countries where specialist care is lacking.

“We are never going to get enough pediatric [musculoskeletal] specialists,” said Dr. Foster. “We have to reach out to the existing workforce and help them help us. These individuals can help raise awareness about suspected diagnoses, help initiate investigations and care.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Currently the task force is developing a novel advocacy campaign (RUN; Rheumatology Unmet Needs) centered on patient stories. This will focus on the general public but also healthcare professionals and healthcare planners, using industry for sponsorship.

The campaign will help fund SPRINT (Spreading Rheumatology Internationally Together) to help build the workforce capacity. This program will expand on previous work with free remote education targeting non-expert members of the medical team, with a priority of reaching low-resource settings. These campaigns will be released over the next 12–18 months. 

 The Pediatric Rheumatologic Workforce

Dr. Scott

Other projects tackled similar concerns of building the overall workforce through education. Chris Scott, MBChb, head of the Division of Paediatric Rheumatology at the University of Cape Town, South Africa, and another co-chair of the Paediatric Global Musculoskeletal Task Force, shared details of a similar project.

Dr. Scott explained that a vicious cycle can occur with lack of access to care. A lack of access leads to missed diagnoses and lack of rheumatology research. This can lead to a false perception of rarity, which leads to further de-prioritization of policies promoting rheumatology education and services, causing further shortages in the workforce and poorer outcomes.

Page: 1 2 3 4 5 6 7 8 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsProfessional Topics Tagged with:ACR Convergence 2021International

Related Articles

    Prospects for Treating Patients with Arthritis in African Countries with Few Rheumatologists

    June 14, 2017

    At present, the U.S. has approximately 5,000 full-time adult rheumatologists. By the year 2025, that number will decline to roughly 3,600.1 Sounds dire, right? Hold that thought. Question: What country has 99 million people and no adult rheumatologists? ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAnswer: Ethiopia.2 The Nigerian Story And then there is Africa’s most populous country,…

    2015 ACR/ARHP Annual Meeting: Global Challenges in Rheumatic Disease Care

    April 15, 2016

    SAN FRANCISCO—To convey the plight of rheumatology patients in sub-Saharan Africa, Girish Mody, MD, head of rheumatology at the University of KwaZulu-Natal in South Africa and past president of the African League of Associations for Rheumatology, recounted a story during the 2015 ACR/ARHP Annual Meeting from the World Health Organization about a diabetes patient. The…

    A World of Difference: Updates from the Global Rheumatology Summit

    January 20, 2023

    The second annual Global Rheumatology Summit focused on climate change, conflict and migration, as well as other global issues in rheumatology.

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences